Evidence map›Paper›PMID 36880906›Full record

ArticleJournal of substance use and addiction treatment2023

Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities.

Danielle A Ryan, Iván D Montoya, Peter J Koutoujian, Kashif Siddiqi, Edmond Hayes, Philip J Jeng, Techna Cadet, Kathryn E McCollister, Sean M Murphy

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024
    Review
  13. Review
  14. Article
  15. Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2024
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danielle A RyanWeill Cornell Medical College, Department of Population Health Sciences, 425 East 61(st) Street, Suite 301, New York, NY 10065, United States of America. Electronic address: Dar4006@med.cornell.edu.
Iván D MontoyaUniversity of Miami Miller School of Medicine, Department of Public Health Sciences, 1120 N.W. 14(th) Street, Suite 1024, Miami, FL 33136, United States of America.
Peter J KoutoujianMiddlesex House of Corrections and Jail, 269 Treble Cove Rd., North Billerica, MA 01862, United States of America.
Kashif SiddiqiMiddlesex House of Corrections and Jail, 269 Treble Cove Rd., North Billerica, MA 01862, United States of America.
Edmond HayesFranklin County Jail, 160 Elm St., Greenfield, MA 01301, United States of America.
Philip J JengWeill Cornell Medical College, Department of Population Health Sciences, 425 East 61(st) Street, Suite 301, New York, NY 10065, United States of America.
Techna CadetWeill Cornell Medical College, Department of Population Health Sciences, 425 East 61(st) Street, Suite 301, New York, NY 10065, United States of America.
Kathryn E McCollisterUniversity of Miami Miller School of Medicine, Department of Public Health Sciences, 1120 N.W. 14(th) Street, Suite 1024, Miami, FL 33136, United States of America.
Sean M MurphyWeill Cornell Medical College, Department of Population Health Sciences, 425 East 61(st) Street, Suite 301, New York, NY 10065, United States of America.

Funding

Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yuhua Bao · 2015 to 2026
$20.7M
Massachusetts Justice Cooperative Opioid Innovation Network (JCOIN) Research CenterUG1DA050067 · NIDA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI EVANS, ELIZABETH A. · 2019 to 2023
$10.5M
Health and Economic Outcomes of Treatment with Extended-Release Naltrexone Among Pre-Release Prisoners with Opioid Use DisorderR01DA046721 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI MURPHY, SEAN M. · 2019 to 2022
$1.6M
NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA046721NIDA NIH HHS UG1 DA050067
6 · The paper itself

Abstract

backgroundGiven the personal and public consequences of untreated/undertreated OUD among persons involved in the justice system, an increasing number of jails and prisons are incorporating medication for opioid use disorder (MOUD) into their system. Estimating the costs of implementing and sustaining a particular MOUD program is vital to detention facilities, which typically face modest, fixed health care budgets. We developed a customizable budget impact tool to estimate the implementation and sustainment costs of numerous MOUD delivery models for detention facilities.

methodsThe aim is to describe the tool and present an application of a hypothetical MOUD model. The tool is populated with resources required to implement and sustain various MOUD models in detention facilities. We identified resources via micro-costing techniques alongside randomized clinical trials. The resource-costing method is used to assign values to resources. Resources/costs are categorized as (a) fixed, (b) time-dependent, and (c) variable. Implementation costs include (a), (b), and (c) over a specified timeframe. Sustainment costs include (b) and (c). The MOUD model example entails offering all three FDA-approved medications, with methadone and buprenorphine provided by vendors, and naltrexone by the jail/prison facility.

resultsFixed resources/costs are incurred only once, including accreditation fees and trainings. Time-dependent resources/costs are recurring, but fixed over a given time-period; e.g., medication delivery and staff meetings. Variable resources/costs are those that are a direct function of the number of persons treated, such as the medication provided to each patient. Using nationally representative prices, we estimated fixed/sustainment costs to be $2919/patient, over 1 year. This article estimates annual sustainment costs to be $2885/patient.

conclusionThe tool will serve as a valuable asset to jail/prison leadership, policymakers, and other stakeholders interested in identifying/estimating the resources and costs associated with alternative MOUD delivery models, from the planning stages through sustainment.

Indexed as

JailsOpioid-Related DisordersBudgetsHumansMethadonePrisonsMethadoneBudget impact toolGuidelineIncarcerationJailMedication for opioid use disorderPrison

Identifiers

PMID36880906
PMCPMC10084043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.